Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Podcasts

Andreas Hochhaus, MD, Talks About the ASCEMBL Trial, Eliminating LSCs in CML

In this podcast, Andreas Hochhaus, MD, University Medical Center Jena, Germany, discusses the significance of the ASCEMBL trial presented at the virtual 2020 ASH Annual Meeting and Exposition, and proposes the question of how to eliminate persisting leukemic stem cells (LSCs) in chronic myeloid leukemia (CML).

 

Advertisement

Advertisement

Advertisement

Advertisement